Cantel Medical Reports Record Performance on 15% Sales Increase with EPS of $0.25 vs. $0.24 ($0.22 as Adjusted) for Fourth Quarter

LITTLE FALLS, N.J., Sept. 26, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) reported record net income of $10,213,000, or $0.25 per diluted share, on a 15% increase in sales to a record $113,973,000 for the fourth quarter ended July 31, 2013. This compares with net income of $9,649,000,or $0.24 per diluted share, on sales of $98,693,000 for the fourth quarter ended July 31, 2012, inclusive of a $0.02 favorable tax benefit related to the closing of our Japan subsidiary.

Help employers find you! Check out all the jobs and post your resume.